These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 9617748)

  • 21. The antinociceptive effects of centrally administered CDP-choline on acute pain models in rats: the involvement of cholinergic system.
    Hamurtekin E; Gurun MS
    Brain Res; 2006 Oct; 1117(1):92-100. PubMed ID: 16942753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The antinociceptive effects of alpha7 nicotinic agonists in an acute pain model.
    Damaj MI; Meyer EM; Martin BR
    Neuropharmacology; 2000 Oct; 39(13):2785-91. PubMed ID: 11044748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nicotine Enhances the Hypnotic and Hypothermic Effects of Alcohol in the Mouse.
    Slater CA; Jackson A; Muldoon PP; Dawson A; O'Brien M; Soll LG; Abdullah R; Carroll FI; Tapper AR; Miles MF; Banks ML; Bettinger JC; Damaj IM
    Alcohol Clin Exp Res; 2016 Jan; 40(1):62-72. PubMed ID: 26727524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The identification of novel structural compound classes exhibiting high affinity for neuronal nicotinic acetylcholine receptors and analgesic efficacy in preclinical models of pain.
    Meyer MD; Decker MW; Rueter LE; Anderson DJ; Dart MJ; Kim KH; Sullivan JP; Williams M
    Eur J Pharmacol; 2000 Mar; 393(1-3):171-7. PubMed ID: 10771011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potentiation of analgesic efficacy but not side effects: co-administration of an α4β2 neuronal nicotinic acetylcholine receptor agonist and its positive allosteric modulator in experimental models of pain in rats.
    Zhu CZ; Chin CL; Rustay NR; Zhong C; Mikusa J; Chandran P; Salyers A; Gomez E; Simler G; Lewis LG; Gauvin D; Baker S; Pai M; Tovcimak A; Brown J; Komater V; Fox GB; Decker MW; Jacobson PB; Gopalakrishnan M; Lee CH; Honore P
    Biochem Pharmacol; 2011 Oct; 82(8):967-76. PubMed ID: 21620806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the rat.
    Kowaluk EA; Mikusa J; Wismer CT; Zhu CZ; Schweitzer E; Lynch JJ; Lee CH; Jiang M; Bhagwat SS; Gomtsyan A; McKie J; Cox BF; Polakowski J; Reinhart G; Williams M; Jarvis MF
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1165-74. PubMed ID: 11082454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nicotinic cholinergic receptors: potential targets for inflammatory pain relief.
    Lawand NB; Lu Y; Westlund KN
    Pain; 1999 Mar; 80(1-2):291-9. PubMed ID: 10204742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antinociceptive and pharmacological effects of metanicotine, a selective nicotinic agonist.
    Damaj MI; Glassco W; Aceto MD; Martin BR
    J Pharmacol Exp Ther; 1999 Oct; 291(1):390-8. PubMed ID: 10490929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido[2, 3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties: I. In vitro characterization and acute antinociceptive effects in the mouse.
    Jarvis MF; Yu H; Kohlhaas K; Alexander K; Lee CH; Jiang M; Bhagwat SS; Williams M; Kowaluk EA
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1156-64. PubMed ID: 11082453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potent antinociceptive effects of TRK-820, a novel kappa-opioid receptor agonist.
    Endoh T; Matsuura H; Tajima A; Izumimoto N; Tajima C; Suzuki T; Saitoh A; Suzuki T; Narita M; Tseng L; Nagase H
    Life Sci; 1999; 65(16):1685-94. PubMed ID: 10573186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for nicotinic receptors potentially modulating nociceptive transmission at the level of the primary sensory neuron: studies with F11 cells.
    Puttfarcken PS; Manelli AM; Arneric SP; Donnelly-Roberts DL
    J Neurochem; 1997 Sep; 69(3):930-8. PubMed ID: 9282914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of nicotinic acetylcholine receptor agonists in assays of acute pain-stimulated and pain-depressed behaviors in rats.
    Freitas KC; Carroll FI; Negus SS
    J Pharmacol Exp Ther; 2015 Nov; 355(2):341-50. PubMed ID: 26359313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The antinociceptive effects of nicotinic partial agonists varenicline and sazetidine-A in murine acute and tonic pain models.
    AlSharari SD; Carroll FI; McIntosh JM; Damaj MI
    J Pharmacol Exp Ther; 2012 Sep; 342(3):742-9. PubMed ID: 22678099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analgesic effects of Sazetidine-A, a new nicotinic cholinergic drug.
    Cucchiaro G; Xiao Y; Gonzalez-Sulser A; Kellar KJ
    Anesthesiology; 2008 Sep; 109(3):512-9. PubMed ID: 18719450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of spinal wide dynamic range neurons by intracutaneous microinjection of nicotine.
    Jinks SL; Carstens E
    J Neurophysiol; 1999 Dec; 82(6):3046-55. PubMed ID: 10601440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antinociceptive effects of novel epibatidine analogs through activation of α4β2 nicotinic receptors.
    Li W; Cai J; Wang BH; Huang L; Fan J; Wang Y
    Sci China Life Sci; 2018 Jun; 61(6):688-695. PubMed ID: 29435707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of morphine, nicotine and epibatidine on lymphocyte activity and hypothalamic-pituitary-adrenal axis responses.
    Mellon RD; Bayer BM
    J Pharmacol Exp Ther; 1999 Feb; 288(2):635-42. PubMed ID: 9918569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analgesic and toxic effects of neonicotinoid insecticides in mice.
    Tomizawa M; Cowan A; Casida JE
    Toxicol Appl Pharmacol; 2001 Nov; 177(1):77-83. PubMed ID: 11708903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repeated administration of nicotine attenuates the development of morphine tolerance and dependence in mice.
    Haghparast A; Khani A; Naderi N; Alizadeh AM; Motamedi F
    Pharmacol Biochem Behav; 2008 Feb; 88(4):385-92. PubMed ID: 17915302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-activity studies related to ABT-594, a potent nonopioid analgesic agent: effect of pyridine and azetidine ring substitutions on nicotinic acetylcholine receptor binding affinity and analgesic activity in mice.
    Holladay MW; Bai H; Li Y; Lin NH; Daanen JF; Ryther KB; Wasicak JT; Kincaid JF; He Y; Hettinger AM; Huang P; Anderson DJ; Bannon AW; Buckley MJ; Campbell JE; Donnelly-Roberts DL; Gunther KL; Kim DJ; Kuntzweiler TA; Sullivan JP; Decker MW; Arneric SP
    Bioorg Med Chem Lett; 1998 Oct; 8(19):2797-802. PubMed ID: 9873625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.